Gene Symbol | TNFRSF11A |
Entrez ID | 8792 |
Uniprot ID | Q9Y6Q6 |
Description | tumor necrosis factor receptor superfamily member 11a |
Chromosomal Location | chr18: 62,325,287-62,391,292 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001503 |
ossification |
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. |
IEA |
BP |
GO:0002250 |
adaptive immune response |
An immune response based on directed amplification of specific receptors for antigen produced through a somatic diversification process, and allowing for enhanced response to subsequent exposures to the same antigen (immunological memory). |
IMP |
BP |
GO:0002548 |
monocyte chemotaxis |
The movement of a monocyte in response to an external stimulus. |
NAS |
BP |
GO:0006954 |
inflammatory response |
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
IBA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
TAS |
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
TAS |
BP |
GO:0009314 |
response to radiation |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation. |
IEA |
BP |
GO:0030316 |
osteoclast differentiation |
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue. |
IMP |
BP |
GO:0032496 |
response to lipopolysaccharide |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
IBA|ISS |
BP |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway |
A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
ISS|TAS |
BP |
GO:0034097 |
response to cytokine |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
IMP |
BP |
GO:0034612 |
response to tumor necrosis factor |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
ISS |
BP |
GO:0042981 |
regulation of apoptotic process |
Any process that modulates the occurrence or rate of cell death by apoptotic process. |
IBA |
BP |
GO:0043507 |
positive regulation of JUN kinase activity |
Any process that activates or increases the frequency, rate or extent of JUN kinase activity. |
IMP |
BP |
GO:0048535 |
lymph node development |
The process whose specific outcome is the progression of lymph nodes over time, from their formation to the mature structure. A lymph node is a round, oval, or bean shaped structure localized in clusters along the lymphatic vessels, with a distinct internal structure including specialized vasculature and B- and T-zones for the activation of lymphocytes. |
IEA |
BP |
GO:0051091 |
positive regulation of sequence-specific DNA binding transcription factor activity |
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
IDA|ISS |
BP |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity |
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
IDA|IMP |
BP |
GO:0060086 |
circadian temperature homeostasis |
Any homeostatic process in which an organism modulates its internal body temperature at different values with a regularity of approximately 24 hours. |
ISS |
BP |
GO:0060749 |
mammary gland alveolus development |
The progression of the mammary gland alveolus over time, from its formation to its mature state. The mammary gland alveolus is a sac-like structure that is found in the mature gland. |
IEA |
BP |
GO:0070555 |
response to interleukin-1 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
ISS |
BP |
GO:0071812 |
positive regulation of fever generation by positive regulation of prostaglandin secretion |
Any process that increases the rate or extent of fever generation via positive regulation of the frequency, rate or extent of the regulated release of a prostaglandin from a cell. |
ISS |
BP |
GO:0071847 |
TNFSF11-mediated signaling pathway |
A series of molecular signals initiated by the binding of tumor necrosis factor ligand superfamily member 11 (TNFSF11) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IMP |
BP |
GO:0071848 |
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling |
Any TNFSF11-mediated signaling process that increases the rate, frequency, or extent of the ERK1 and ERK2 cascade. |
IMP |
BP |
GO:0097190 |
apoptotic signaling pathway |
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. |
IBA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
IBA |
CC |
GO:0009897 |
external side of plasma membrane |
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
IDA |
MF |
GO:0004872 |
receptor activity |
Combining with an extracellular or intracellular messenger to initiate a change in cell activity. |
TAS |
MF |
GO:0004888 |
transmembrane signaling receptor activity |
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction. |
IDA |
MF |
GO:0005031 |
tumor necrosis factor-activated receptor activity |
Combining with tumor necrosis factor, a proinflammatory cytokine produced by monocytes and macrophages, to initiate a change in cell function. |
IBA|ISS |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0019955 |
cytokine binding |
Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity. |
IPI |
MF |
GO:0046872 |
metal ion binding |
Interacting selectively and non-covalently with any metal ion. |
IEA |
Domain ID | Description |
---|---|
IPR001368 |
TNFR/NGFR cysteine-rich region |
IPR022323 |
Tumour necrosis factor receptor 11 |
IPR022361 |
Tumour necrosis factor receptor 11A |
IPR034040 |
Tumor necrosis factor receptor 11A, N-terminal |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
hsa04064 |
NF-kappa B signaling pathway |
KEGG |
hsa04380 |
Osteoclast differentiation |
KEGG |
hsa04917 |
Prolactin signaling pathway |
KEGG |
hsa05323 |
Rheumatoid arthritis |
KEGG |
WP3594 |
Circadian rythm related genes |
WikiPathways |
WP2018 |
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway |
WikiPathways |
WP12 |
Osteoclast Signaling |
WikiPathways |
h_ranklPathway |
Bone Remodelling |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0023434 |
Chronic Lymphocytic Leukemia |
C0026896 |
Myasthenia Gravis |
C0029401 |
Osteitis Deformans |
C0029463 |
Osteosarcoma |
Database Name |
---|
DGA |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
CBLB |
868 |
Q13191 |
0.52 |
TNFSF11 |
8600 |
O14788 |
0.52 |
GAB2 |
9846 |
Q9UQC2 |
0.55 |
MAP3K7 |
6885 |
O43318 |
0.73 |
TRAF1 |
7185 |
Q13077 |
0.96 |
TRAF2 |
7186 |
Q12933 |
0.96 |
TRAF3 |
7187 |
Q13114 |
0.96 |
TRAF5 |
7188 |
O00463 |
0.96 |
TRAF6 |
7189 |
Q9Y4K3 |
0.96 |
AKT1 |
207 |
P31749 |
0.00 |
FCGR2A |
2212 |
P12318 |
0.00 |
FOS |
2353 |
P01100 |
0.00 |
TMPRSS15 |
5651 |
P98073 |
0.49 |
FHL2 |
2274 |
Q14192 |
0.52 |
SRC |
6714 |
P12931 |
0.52 |
CBL |
867 |
P22681 |
0.55 |
SP1 |
6667 |
P08047 |
0.63 |
NXF1 |
10482 |
Q9UBU9 |
0.63 |
TAB2 |
23118 |
Q9NYJ8 |
0.73 |